Immune system study in sepsis patients
Part of Infections clinical trials.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Must be in the ICU with sepsis or a similar severe illness
- For the sepsis group: must have signs like fast breathing, confusion, or low blood pressure due to infection
- Must not have had chemotherapy or radiation for cancer in the last 6 weeks
- Must not be taking certain immune-suppressing medications or high-dose steroids (more than 20 mg of prednisone daily)
- Must not have an autoimmune disease (e.g., lupus, multiple sclerosis), HIV/AIDS, or active hepatitis B or C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study is looking at how the immune system changes in people with sepsis. If you have been diagnosed with sepsis in the last 48 hours, researchers want to better understand your immune response, which could help improve treatments.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.